Literature DB >> 33098766

A Hyper-IgM Syndrome Mutation in Activation-Induced Cytidine Deaminase Disrupts G-Quadruplex Binding and Genome-wide Chromatin Localization.

William T Yewdell1, Youngjun Kim2, Priyanka Chowdhury2, Colleen M Lau1, Ryan M Smolkin3, Kalina T Belcheva4, Keith C Fernandez2, Montserrat Cols1, Wei-Feng Yen1, Bharat Vaidyanathan2, Davide Angeletti5, Adrian B McDermott6, Jonathan W Yewdell5, Joseph C Sun7, Jayanta Chaudhuri8.   

Abstract

Precise targeting of activation-induced cytidine deaminase (AID) to immunoglobulin (Ig) loci promotes antibody class switch recombination (CSR) and somatic hypermutation (SHM), whereas AID targeting of non-Ig loci can generate oncogenic DNA lesions. Here, we examined the contribution of G-quadruplex (G4) nucleic acid structures to AID targeting in vivo. Mice bearing a mutation in Aicda (AIDG133V) that disrupts AID-G4 binding modeled the pathology of hyper-IgM syndrome patients with an orthologous mutation, lacked CSR and SHM, and had broad defects in genome-wide AIDG133V chromatin localization. Genome-wide analyses also revealed that wild-type AID localized to MHCII genes, and AID expression correlated with decreased MHCII expression in germinal center B cells and diffuse large B cell lymphoma. Our findings indicate a crucial role for G4 binding in AID targeting and suggest that AID activity may extend beyond Ig loci to regulate the expression of genes relevant to the physiology and pathology of activated B cells.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AID; CSR; DLBCL; G-quadruplex; G4; HIGM; MHC class II; MHCII; SHM; activation-induced cytidine deaminase; class switch recombination; diffuse large B cell lymphoma; germinal center B cells; hyper-IgM syndrome; somatic hypermutation

Mesh:

Substances:

Year:  2020        PMID: 33098766     DOI: 10.1016/j.immuni.2020.10.003

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  7 in total

1.  The role of HIRA-dependent H3.3 deposition and its modifications in the somatic hypermutation of immunoglobulin variable regions.

Authors:  Guojun Yu; Yongwei Zhang; Varun Gupta; Jinghang Zhang; Thomas MacCarthy; Zhi Duan; Matthew D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-14       Impact factor: 12.779

2.  TET deficiency perturbs mature B cell homeostasis and promotes oncogenesis associated with accumulation of G-quadruplex and R-loop structures.

Authors:  Vipul Shukla; Daniela Samaniego-Castruita; Zhen Dong; Edahí González-Avalos; Qingqing Yan; Kavitha Sarma; Anjana Rao
Journal:  Nat Immunol       Date:  2021-12-22       Impact factor: 31.250

3.  A Bayesian model based computational analysis of the relationship between bisulfite accessible single-stranded DNA in chromatin and somatic hypermutation of immunoglobulin genes.

Authors:  Guojun Yu; Yingru Wu; Zhi Duan; Catherine Tang; Haipeng Xing; Matthew D Scharff; Thomas MacCarthy
Journal:  PLoS Comput Biol       Date:  2021-09-07       Impact factor: 4.475

Review 4.  The Relevance of G-Quadruplexes for DNA Repair.

Authors:  Rebecca Linke; Michaela Limmer; Stefan A Juranek; Annkristin Heine; Katrin Paeschke
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

5.  Triple-helix potential of the mouse genome.

Authors:  Kaku Maekawa; Shintaro Yamada; Rahul Sharma; Jayanta Chaudhuri; Scott Keeney
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-03       Impact factor: 12.779

6.  AFF3, a susceptibility factor for autoimmune diseases, is a molecular facilitator of immunoglobulin class switch recombination.

Authors:  Shin-Ichi Tsukumo; Poorani Ganesh Subramani; Noé Seija; Mizuho Tabata; Yoichi Maekawa; Yuya Mori; Chieko Ishifune; Yasushi Itoh; Mineto Ota; Keishi Fujio; Javier M Di Noia; Koji Yasutomo
Journal:  Sci Adv       Date:  2022-08-24       Impact factor: 14.957

7.  Characterization of DNA G-Quadruplex Structures in Human Immunoglobulin Heavy Variable (IGHV) Genes.

Authors:  Catherine Tang; Thomas MacCarthy
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.